ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,680Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 2456

$940K Total Retail Price of All Prescriptions

Rank: 43 out of 2456

752 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 752 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 752 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 17,481 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,122 1,060 1 9
FUROSEMIDE 748 718 2 8
LEVOTHYROXINE SODIUM 600 545 3 4
ATENOLOL 557 534 4 6
AMLODIPINE BESYLATE 549 547 5 5
OMEPRAZOLE 523 501 6 3
SIMVASTATIN 493 472 7 2
LISINOPRIL 471 437 8 1
METOPROLOL TARTRATE 421 395 9 10
TRAZODONE HCL 396 379 10 17
DONEPEZIL HCL 347 347 11 23
ATORVASTATIN CALCIUM 338 325 12 12
CITALOPRAM HBR 329 317 13 14
SERTRALINE HCL 272 268 14 21
PANTOPRAZOLE SODIUM 267 263 15 37
MIRTAZAPINE 260 254 16 29
METFORMIN HCL 257 226 17 11
METOPROLOL SUCCINATE 248 245 18 13
HYDROCHLOROTHIAZIDE 244 214 19 7
NAMENDA 241 230 20 42
TRIAMTERENE-HCTZ 223 213 21 53
POTASSIUM CHLORIDE 218 216 22 33
ALENDRONATE SODIUM 183 181 23 19
RANITIDINE HCL 181 157 24 31
NITROGLYCERIN PATCH 180 174 25 134
CRESTOR 177 147 26 25
DIGOXIN 169 169 27 49
GLIMEPIRIDE 168 168 28 74
ALLOPURINOL 140 133 29 27
LIDODERM 138 138 30 58
POLYETHYLENE GLYCOL 3350 136 121 31 64
CARVEDILOL 131 129 32 54
OLANZAPINE 127 118 33 57
LEVEMIR 125 125 34 174
PREDNISONE 122 113 35 39
VENLAFAXINE HCL ER 120 114 36 92
FLUTICASONE PROPIONATE 118 109 37 30
DIOVAN 116 106 38 26
TAMSULOSIN HCL 114 114 39 32
DILTIAZEM 24HR CD 114 114 39 113
IPRATROPIUM-ALBUTEROL 112 104 41 85
QUETIAPINE FUMARATE 108 107 42 47
ESCITALOPRAM OXALATE 107 102 43 116
PRAVASTATIN SODIUM 107 99 43 15
GABAPENTIN 100 89 45 16
RISPERIDONE 96 95 46 50
PROAIR HFA 85 74 47 22
NEXIUM 84 42 48 80
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 80 49 41
ISOSORBIDE MONONITRATE ER 80 80 50 48
LOSARTAN POTASSIUM 77 64 51 18
TERAZOSIN HCL 76 63 52 76
CARBIDOPA-LEVODOPA 73 73 53 82
GLIPIZIDE 71 66 54 46
DIVALPROEX SODIUM 71 71 54 51
ZOLPIDEM TARTRATE 70 68 56 28
NYSTOP 70 61 56 125
NOVOLOG 69 69 58 100
LAMOTRIGINE 69 67 58 120
KLOR-CON M20 69 69 58 69
HYDROCODONE-ACETAMINOPHEN 68 66 S3 61 20
JANUVIA 65 65 62 81
CLOPIDOGREL 65 62 62 55
CYMBALTA 63 56 64 65
BUMETANIDE 63 62 64 167
LIPITOR 59 59 66 63
COLCRYS 59 59 66 171
ADVAIR DISKUS 58 42 68 36
NYSTATIN 58 54 68 99
PHENYTOIN SODIUM EXTENDED 57 40 70 140
HUMALOG 55 55 71 123
FINASTERIDE 55 55 71 66
FLUOXETINE HCL 54 50 73 45
ENOXAPARIN SODIUM 54 54 73 186
LEVETIRACETAM 54 42 73 90
CARBAMAZEPINE 54 0 73 155
ALBUTEROL SULFATE 53 53 77 165
LANTUS 51 51 78 44
SPIRONOLACTONE 51 51 78 73
AGGRENOX 51 51 78 246
EVISTA 50 50 81 143
SPIRIVA 50 47 81 43
AZITHROMYCIN 50 49 81 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.